Remuzzi G - Search Results

1

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Shimizu M, Shobu Y, Kikuchi M. Schulman G, et al. Among authors: remuzzi g. BMC Nephrol. 2016 Sep 30;17(1):141. doi: 10.1186/s12882-016-0357-9. BMC Nephrol. 2016. PMID: 27716149 Free PMC article. Clinical Trial.

2

ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy.

Ruggenenti P, Perna A, Remuzzi G. Ruggenenti P, et al. Among authors: remuzzi g. J Am Soc Nephrol. 2001 Dec;12(12):2832-2837. doi: 10.1681/ASN.V12122832. J Am Soc Nephrol. 2001. PMID: 11729254

3

Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.

Pisoni R, Faraone R, Ruggenent P, Remuzzi G. Pisoni R, et al. Among authors: remuzzi g. J Nephrol. 2002 Jul-Aug;15(4):428-30. J Nephrol. 2002. PMID: 12243375 Review.

4

Halting the progression of chronic nephropathy.

Campbell RC, Ruggenenti P, Remuzzi G. Campbell RC, et al. Among authors: remuzzi g. J Am Soc Nephrol. 2002 Nov;13 Suppl 3:S190-5. doi: 10.1097/01.asn.0000032522.29672.0a. J Am Soc Nephrol. 2002. PMID: 12466313 Review.

5

Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results.

Remuzzi G, Ruggenenti P, Perna A, Dimitrov BD, de Zeeuw D, Hille DA, Shahinfar S, Carides GW, Brenner BM; RENAAL Study Group. Remuzzi G, et al. J Am Soc Nephrol. 2004 Dec;15(12):3117-25. doi: 10.1097/01.ASN.0000146423.71226.0C. J Am Soc Nephrol. 2004. PMID: 15579515 Clinical Trial.

6

Hyperuricemia in kidney transplantation.

Perico N, Codreanu I, Caruso M, Remuzzi G. Perico N, et al. Among authors: remuzzi g. Contrib Nephrol. 2005;147:124-131. doi: 10.1159/000082550. Contrib Nephrol. 2005. PMID: 15604612 Review.

7

Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.

Haller H, Viberti GC, Mimran A, Remuzzi G, Rabelink AJ, Ritz E, Rump LC, Ruilope LM, Katayama S, Ito S, Izzo JL Jr, Januszewicz A. Haller H, et al. Among authors: remuzzi g. J Hypertens. 2006 Feb;24(2):403-8. doi: 10.1097/01.hjh.0000202820.56201.e6. J Hypertens. 2006. PMID: 16508590 Clinical Trial.

8

Progression of chronic kidney disease: insights from animal models.

Zoja C, Abbate M, Remuzzi G. Zoja C, et al. Among authors: remuzzi g. Curr Opin Nephrol Hypertens. 2006 May;15(3):250-7. doi: 10.1097/01.mnh.0000222691.53970.83. Curr Opin Nephrol Hypertens. 2006. PMID: 16609291 Review.

9

Hepatitis C infection and chronic renal diseases.

Perico N, Cattaneo D, Bikbov B, Remuzzi G. Perico N, et al. Among authors: remuzzi g. Clin J Am Soc Nephrol. 2009 Jan;4(1):207-20. doi: 10.2215/CJN.03710708. Epub 2009 Jan 7. Clin J Am Soc Nephrol. 2009. PMID: 19129320 Review.

10

Aldosterone and progression of kidney disease.

Cortinovis M, Perico N, Cattaneo D, Remuzzi G. Cortinovis M, et al. Among authors: remuzzi g. Ther Adv Cardiovasc Dis. 2009 Apr;3(2):133-43. doi: 10.1177/1753944708100409. Epub 2009 Jan 26. Ther Adv Cardiovasc Dis. 2009. PMID: 19171691 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,537 results

Search Page

Filters